Relief Therapeutics Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLF.SW research report →
Price Chart
About the company
Relief Therapeutics Holding AG is a biopharmaceutical company, based in Geneva, Switzerland, and established in 2013. The firm is dedicated to providing therapeutic solutions for patients globally, including Switzerland, the rest of Europe, and North America, who suffer from serious diseases with significant unmet medical needs. The company's strategy centers on advancing clinical-stage programs, leveraging molecules that possess an established history of human use.
- CEO
- Jeremy Meinen
- IPO
- 2009
- Employees
- 31
- HQ
- Geneva, CH
Get TickerSpark's AI analysis on RLF.SW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
Latest fiscal year · YoY change
- Revenue
- $8.42M+39.5%
- Gross Profit
- $5.84M+42.0%
- Op Income
- $-18,885,000
- Net Income
- $-17,119,000+82.6%
- EPS
- $-1.36+83.7%
- OCF Growth
- +83.4%
- FCF Growth
- +82.9%
- 52W High
- $4.59
- 52W Low
- $1.65
- 50D MA
- $2.91
- 200D MA
- $2.61
- Beta
- -0.33
- RSI (14)
- 53
- Avg Volume
- 41.21K
No earnings-call transcripts are available for RLF.SW yet.
- Free Float
- 76.3%
- Shares Outstanding
- 12.58M
- Float Shares
- 9.60M
Our RLF.SW coverage
Recent articles, reports, and earnings notes.
No research on RLF.SW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RLF.SW report →